guest ::
| Home > Publications Database > The effect of cognition and age on the efficacy of psychotherapy in late-life depression. > print |
| Home > Publications Database > The effect of cognition and age on the efficacy of psychotherapy in late-life depression. > print |
| 001 | 280954 | ||
| 005 | 20250918102643.0 | ||
| 024 | 7 | _ | |a 10.1016/j.jad.2025.119881 |2 doi |
| 024 | 7 | _ | |a pmid:40669702 |2 pmid |
| 024 | 7 | _ | |a 0165-0327 |2 ISSN |
| 024 | 7 | _ | |a 1573-2517 |2 ISSN |
| 037 | _ | _ | |a DZNE-2025-01036 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Bewernick, Bettina |b 0 |
| 245 | _ | _ | |a The effect of cognition and age on the efficacy of psychotherapy in late-life depression. |
| 260 | _ | _ | |a Amsterdam [u.a.] |c 2025 |b Elsevier Science |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1758104758_31850 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Cognitive impairment is prevalent in older age and in patients with depression, which may limit the efficacy of psychotherapy for late-life depression (LLD). We analyzed the effect of age and baseline cognition on the efficacy of psychotherapy in LLD.This secondary analysis of a randomized controlled multicenter study included 213 participants (60-92 years) with moderate to severe depression who had received either supportive psychotherapy (SUI) or an LLD-specific cognitive behavioral therapy (LLD-CBT), both of which led to a substantial reduction in depressive symptoms. We examined the influence of age and baseline cognition, assessed with the CERAD-plus neuropsychological battery, on changes in the Geriatric Depression Scale (GDS) at the end of treatment and at 6-month follow-up. Trial registration at ClinicalTrials.gov (NCT03735576) and DRKS (DRKS00013769).Baseline cognition was slightly below norms (<1SD), with 15 % of patients meeting criteria for Mild Cognitive Impairment (MCI). GDS change at the end of treatment was not significantly associated with baseline cognition or MCI status, although additional interaction analyses suggest that, in the SUI group, lower baseline cognitive performance was associated with reduced treatment efficacy at follow-up only. Additionally, we found that higher age predicted a smaller reduction in GDS scores both at end-of-treatment and at follow-up in both treatment groups.Higher age, but not lower cognitive performance, was associated with reduced psychotherapy efficacy. Thus, age-related factors should be considered in psychotherapy. |
| 536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a Age |2 Other |
| 650 | _ | 7 | |a Cognition |2 Other |
| 650 | _ | 7 | |a Late-life depression |2 Other |
| 650 | _ | 7 | |a Predictors of treatment efficacy |2 Other |
| 650 | _ | 7 | |a Psychotherapy |2 Other |
| 700 | 1 | _ | |a Buschmann, Julijana |b 1 |
| 700 | 1 | _ | |a Heser, Kathrin |b 2 |
| 700 | 1 | _ | |a Kleineidam, Luca |0 P:(DE-2719)2812139 |b 3 |u dzne |
| 700 | 1 | _ | |a Domschke, Katharina |b 4 |
| 700 | 1 | _ | |a Elsaesser, Moritz |b 5 |
| 700 | 1 | _ | |a Zehender, Nadine |b 6 |
| 700 | 1 | _ | |a Luppa, Melanie |b 7 |
| 700 | 1 | _ | |a Hellmich, Martin |b 8 |
| 700 | 1 | _ | |a Peters, Oliver |0 P:(DE-2719)2811024 |b 9 |u dzne |
| 700 | 1 | _ | |a Froelich, Lutz |b 10 |
| 700 | 1 | _ | |a Riedel-Heller, Steffi |b 11 |
| 700 | 1 | _ | |a Schramm, Elisabeth |b 12 |
| 700 | 1 | _ | |a Hautzinger, Martin |b 13 |
| 700 | 1 | _ | |a Jessen, Frank |0 P:(DE-2719)2000032 |b 14 |u dzne |
| 700 | 1 | _ | |a Dafsari, Forugh S |b 15 |
| 700 | 1 | _ | |a Wagner, Michael |0 P:(DE-2719)2000057 |b 16 |e Last author |u dzne |
| 773 | _ | _ | |a 10.1016/j.jad.2025.119881 |g Vol. 391, p. 119881 - |0 PERI:(DE-600)1500487-9 |p 119881 |t Journal of affective disorders |v 391 |y 2025 |x 0165-0327 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/280954/files/DZNE-2025-01036%20SUP.docx |
| 856 | 4 | _ | |y Restricted |u https://pub.dzne.de/record/280954/files/DZNE-2025-01036.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/280954/files/DZNE-2025-01036.pdf?subformat=pdfa |x pdfa |y Restricted |
| 909 | C | O | |o oai:pub.dzne.de:280954 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 3 |6 P:(DE-2719)2812139 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 9 |6 P:(DE-2719)2811024 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 14 |6 P:(DE-2719)2000032 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 16 |6 P:(DE-2719)2000057 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 914 | 1 | _ | |y 2025 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-28 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-28 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2024-12-28 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2024-12-28 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2024-12-28 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1180 |2 StatID |b Current Contents - Social and Behavioral Sciences |d 2024-12-28 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2024-12-28 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-28 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-28 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2024-12-28 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0130 |2 StatID |b Social Sciences Citation Index |d 2024-12-28 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-28 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2024-12-28 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-28 |
| 920 | 1 | _ | |0 I:(DE-2719)1011201 |k AG Wagner |l Neuropsychology |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1011102 |k AG Jessen |l Clinical Alzheimer’s Disease Research |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)1011201 |
| 980 | _ | _ | |a I:(DE-2719)1011102 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|